Search results
Pfizer Settles Zantac Lawsuits, Agrees To $250M Settlement To Reduce Liability: Report - Pfizer...
Benzinga· 5 hours agoIn a bid to settle thousands of lawsuits over its discontinued heartburn drug Zantac, Pfizer Inc....
2 No-Brainer Dividend Stocks to Buy in May
Motley Fool via Yahoo Finance· 7 days agoTelecom giant AT&T (NYSE: T) and pharmaceutical titan Pfizer (NYSE: PFE) scan as incredible bargains for long-term, income-oriented investors. Read on to...
Vepdegestrant shows promise in breast cancer trial By Investing.com
Investing.com· 1 hour agoArvinas, Inc. (NASDAQ: ARVN) and Pfizer Inc. (NYSE: NYSE:PFE) today announced continued positive...
2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential
The Motley Fool via AOL· 2 days agoAnalysts expect substantially higher revenue potential by the end of the decade, thanks to those...
The 3 Most Undervalued Healthcare Stocks to Buy in May 2024
InvestorPlace via Yahoo Finance· 6 days agoA commonly used strategy for investing is sector rotation. This involves the movement of funds from...
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Pfizer Stock
Motley Fool via Yahoo Finance· 3 days agoFirst, there's a chance that Pfizer stock has significant upside from here. The company's COVID-19...
7 Cheap Value Stocks to Buy Now: May 2024
InvestorPlace· 1 day agoThe major stock market indexes are near record highs. The good news, however, is that investors can still put money to work in today’s market without...
Investing in Pfizer Inc.
Knox Daily· 3 days agoArgus downgraded its Pfizer Inc. [PFE] rating to a Hold from a a Buy in a research...revised their coverage, including Guggenheim’s analysts, who began to cover the
7 F-Rated Stock Picks to Avoid Like the Plague in May
InvestorPlace via Yahoo Finance· 6 days agoThe stock market is off to a washing machine kind of start for 2024, with gains and lulls that keep...
Patent Peril: 3 Stocks at Risk From the FTC's Drug Crusade
InvestorPlace· 2 hours agoSeveral drug stocks are at risk as the Federal Trade Commission is going after pharmaceutical...
